TYK Medicines (HKSE:02410) Marketable Securities: HK$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02410 TYK Medicines Inc HKSE:02410
7 GF Score
Price HK$2.99
! 3 Warning Signs
View Full Analysis

What is TYK Medicines Marketable Securities?

TYK Medicines HKSE:02410 +11.38% 7 Marketable Securities is HK$0.00 Mil as of Dec. 2025. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. TYK Medicines's Marketable Securities for the quarter that ended in Dec. 2025 was HK$0.00 Mil.

TYK Medicines's annual Marketable Securities declined from Dec. 2023 (HK$6.56 Mil) to Dec. 2024 (HK$0.00 Mil) but then stayed the same from Dec. 2024 (HK$0.00 Mil) to Dec. 2025 (HK$0.00 Mil).

TYK Medicines  (HKSE:02410) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

TYK Medicines Marketable Securities Related Terms

TYK Medicines Marketable Securities Historical Data

* Premium members only.

The historical data trend for TYK Medicines's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TYK Medicines Marketable Securities Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Marketable Securities
170.55 6.56 0.00 0.00

TYK Medicines Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial 57.34 0.00 204.24 0.00 0.00
HKSE:02410
7GF Score
TYK Medicines Inc HKSE:02410
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TYK Medicines Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of HK$0.00 Mil mean?
TYK Medicines (HKSE:02410) has a Marketable Securities of HK$0.00 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on TYK Medicines and its competitors.
Is TYK Medicines' Marketable Securities too high?
TYK Medicines' current Marketable Securities is HK$0.00 Mil. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' Marketable Securities compare to VRTX and REGN?
TYK Medicines' Marketable Securities of HK$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on TYK Medicines and its competitors. TYK Medicines's current Marketable Securities is HK$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current Marketable Securities of HK$0.00 Mil. The current Marketable Securities is HK$0.00 Mil. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current Marketable Securities is HK$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TYK Medicines Business Description

Address No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score

Get the complete analysis for HKSE:02410

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.99
Price